March 06, 2026

A human mini-bladder shows the culprit of recurrent infections

A human mini-bladder shows the culprit of recurrent infections

Researchers at EPFL, Heidelberg University and Roche have built a human mini-bladder to show how urine composition weakens bladder tissue, helping infections recur even after antibiotics.

You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information
A human mini-bladder shows the culprit of recurrent infections. EPFL: https://www.epfl.ch/

The bladder is not just a static storage bag; its lining stretches, relaxes, and stays in constant contact with urine whose composition changes with hydration, diet, and disease. Urine can vary widely in salt and solute concentration, and studies on animals have shown that concentrated urine can damage the bladder lining. But how exactly that happens is unclear.

UTIs impact over 400 million people worldwide every year. Most recurrent urinary tract infections (UTIs) are caused by a bacterium, “uropathogenic Escherichia coli”, or UPEC. These bacteria can live in urine, stick to bladder cells, and invade the bladder tissue. Some forms can even hide inside cells or enter dormant states that make them harder to kill. And so far, there has been no human model able to capture the full interaction between urine, bladder tissue, and bacteria over time.

A custom-made human bladder

Now, scientists at EPFL, Roche’s Institute of Human Biology in Basel, and Heidelberg University have developed a human mini-bladder by integrating organoid technology with bioengineering to create a lab-grown model that mimics the organ’s complex architecture.

The mini-bladder recreates the layered structure of the lining of the human bladder, exposes it to real or synthetic urine, and mimics filling and emptying cycles, revealing how urine composition shapes tissue health and bacterial survival during infection.

The work was led by John McKinney (EPFL), Matthias Lütolf (Roche Institute of Human Biology/EPFL), and Vivek Thacker (Heidelberg University). It is published in Nature Communications.

Put to the test

The researchers began by growing primary human bladder cells inside a small microfluidic device. Over several weeks, the cells formed a stratified urothelium (the inner lining of the urinary tract) with a tight barrier, similar to the human bladder. The tissue could stretch and relax, mimicking bladder filling and voiding.

The team then perfused the mini-bladder with urine of different but defined compositions. They compared urine with low solute concentration with urine with high solute concentration. They also infected the mini-bladder with UPEC and monitored its effects during repeated wash cycles that simulate urination. They also ran the tests with common antibiotics, including ciprofloxacin and fosfomycin.

High-solute urine gives bacteria an advantage

The study showed that long-term exposure to high-solute urine damages the bladder tissue. Barriers (“tight junctions”) weakened, more bladder cells died than in control tissues, and the expression of genes involved in immune defense dropped. In contrast, control mini-bladders, exposed to low-solute urine stayed healthier and more resilient.

“When infected with UPEC, mini-bladders exposed to concentrated urine accumulated more bacteria inside the tissue,” says Gauri Paduthol, the study’s first author. “These tissue-associated bacteria were harder to clear with antibiotics. Fosfomycin, a widely used, first-line treatment for UTIs, triggered a surprising response: in high-solute urine, UPEC switched into unusual ‘cell wall-deficient bacteria’ forms that resisted antibiotic treatment.”

The study also found that these cell wall-deficient bacteria were not only present in urine; they were also located deep within the bladder tissue, lodged between cells. After the antibiotic was removed, the surviving bacteria reseeded the infection, providing a direct mechanism for recurrence.

The results suggest that urine composition is an active player in urinary tract infections, and that concentrated urine weakens bladder defenses and helps bacteria survive treatment. This may help explain why some patients suffer repeated infections, especially when urine stays highly concentrated for long periods.

In addition, the newly developed human mini-bladder offers a powerful new tool to study UTIs and test therapies under realistic conditions.

Originalpublication

Paduthol, G., Nikolaev, M., Sharma, K. et al. A microphysiological human mini-bladder reveals urine-urothelium interplay in tissue resilience and UPEC recurrence in urinary tract infections. Nat Commun (2026). https://doi.org/10.1038/s41467-026-68573-3

Animated Z-stack showing a volume of a differentiated mini-bladder stained with phalloidin (orange) and DAPI (cyan). Credit: Paduthol et al 2026.

Our latest News

discover more
Wo Zukunft entsteht: Deutschlands „Innovationsmaschinenräume“ präsentieren sich auf der re:publica 2026

Wo Zukunft entsteht: Deutschlands „Innovationsmaschinenräume“ präsentieren sich auf der re:publica 2026

Wie kann aus wissenschaftlicher Forschung eine konkrete medizinische Therapie entstehen? Im Maschinenraum der Life Sciences leistet bioRN Life Science Cluster genau das: Unter anderem beim Thema Frauengesundheit Heidelberg, 30 April 2026: Frauen sterben früher und werden oft schlechter therapiert. Der Grund dafür: Die medizinische Forschung und Entwicklung waren lange Zeit überwiegend auf männliche Populationen ausgerichtet. […]

AGC Biologics Wins 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance

AGC Biologics Wins 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance

Global CDMO recognized for exceptional quality systems and regulatory track record; named finalist in Excellence in Client Service & Partnership and Manufacturing Operations categories SEATTLE – April 27, 2026 – AGC Biologics, your friendly CDMO expert, is the 2026 recipient of the Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance. The award recognizes the […]

Molecular research: When speed meets precision

Molecular research: When speed meets precision

KIMMDY software visualizes biological processes in motion – conceived and originally developed at HITS, refined and published at the Max Planck Institute for Polymer Research in Mainz Within biological cells, molecules are constantly in motion. Investigating these motions, however, is still difficult, due to the fact that these processes occur on very small length and time […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp